Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2011-03-15

FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for hydrochlorothiazide, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)